Skip to main content

Table 3 Organ equivalent dose and effective dose from 18F-FDG PET/CT with standard CT to adult male and female patients

From: Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates

Organ

Dose from 18F-FDG, mGya

Dose from CT, mGyb

Total dose, mGy

Male (n = 46)

Female (n = 39)

Male (n = 46)

Female (n = 39)

Male (n = 46)

Female (n = 39)

Adrenals

5.1 ± 0.9

6.0 ± 1.0

5.3 ± 1.0

4.6 ± 0.8

10.4 ± 0.9

10.6 ± 0.9

Brain

15.9 ± 3.2

17.3 ± 3.2

6.0 ± 1.0

5.3 ± 0.9

21.9 ± 2.8

22.6 ± 2.9

Breasts

3.6 ± 0.7

4.3 ± 0.8

4.9 ± 0.9

4.2 ± 0.7

8.4 ± 0.8

8.5 ± 0.7

Gallbladder wall

5.4 ± 1.0

6.2 ± 1.8

5.6 ± 1.0

4.9 ± 0.9

11.1 ± 0.9

11.1 ± 1.0

Colon

4.9 ± 0.9

5.9 ± 1.0

5.2 ± 1.0

4.6 ± 0.8

10.2 ± 0.9

10.5 ± 0.9

Small intestine

5.1 ± 0.9

5.7 ± 1.0

5.2 ± 1.0

4.6 ± 0.8

10.3 ± 0.9

10.2 ± 0.9

Stomach wall

4.7 ± 0.9

5.6 ± 1.0

5.7 ± 1.0

4.9 ± 0.9

10.3 ± 0.9

10.5 ± 0.9

Heart wall

29.1 ± 6.2

35.4 ± 6.9

5.9 ± 1.1

5.2 ± 0.9

35.0 ± 5.6

40.6 ± 6.5

Kidneys

4.5 ± 0.8

5.3 ± 0.9

5.8 ± 1.1

5.1 ± 0.9

10.3 ± 0.9

10.3 ± 0.9

Liver

8.9 ± 1.7

11.0 ± 2.0

5.6 ± 1.0

4.8 ± 0.8

14.4 ± 1.4

15.8 ± 1.7

Lungs

8.3 ± 1.7

10.0 ± 1.8

6.3 ± 1.2

5.4 ± 1.0

14.6 ± 1.4

15.4 ± 1.5

Muscle

4.2 ± 0.8

5.0 ± 0.9

3.8 ± 0.7

3.3 ± 0.6

8.0 ± 0.7

8.3 ± 0.7

Ovaries/Testesc

4.6 ± 0.8

7.0 ± 1.2

1.1 ± 0.2

4.3 ± 0.8

5.6 ± 0.8

11.2 ± 1.0

Pancreas

5.2 ± 1.0

6.2 ± 1.0

5.2 ± 1.0

4.5 ± 0.8

10.4 ± 0.9

10.7 ± 0.9

Red marrow

4.2 ± 0.9

4.8 ± 1.0

4.4 ± 0.8

3.8 ± 0.7

8.5 ± 0.8

8.6 ± 0.9

Osteogenic cells

6.2 ± 1.8

67.4 ± 2.0

8.0 ± 1.6

6.9 ± 1.2

14.2 ± 1.5

14.3 ± 1.7

Skin

3.2 ± 0.6

3.7 ± 0.7

3.4 ± 0.6

3.0 ± 0.5

6.6 ± 0.6

6.7 ± 0.6

Spleen

4.4 ± 0.8

5.2 ± 0.9

5.4 ± 1.0

4.7 ± 0.8

9.8 ± 0.9

9.9 ± 0.9

Thymus

4.8 ± 0.9

5.7 ± 1.0

6.4 ± 1.2

5.6 ± 1.0

11.2 ± 1.0

11.3 ± 1.0

Thyroid

4.2 ± 0.8

4.4 ± 0.8

8.3 ± 1.4

7.3 ± 1.3

12.4 ± 1.2

11.7 ± 1.1

Urinary bladder wall

59.1 ± 5.2

79.5 ± 6.7

5.5 ± 1.0

4.8 ± 0.8

64.6 ± 4.8

84.3 ± 6.4

Uterus

–

8.8 ± 1.4

–

4.6 ± 0.8

–

13.4 ± 1.2

Effective dosed

8.1 ± 1.2

10.1 ± 1.4

5.3 ± 1.0

4.6 ± 0.8

13.4 ± 1.1

14.7 ± 1.2

  1. aPatient specific average dose calculated by OLINDA
  2. bPatient specific average dose calculated by ImPACT
  3. cOvaries for female patients/Testes for male patients
  4. dEffective dose in mSv estimated by ICRP Publication 103